Niclosamide: Beyond an antihelminthic drug.

Niclosamide: Beyond an antihelminthic drug.
复制标题

DOI:
10.1016/j.cellsig.2017.04.001
复制
发表时间:
2018-01
影响因子:
4.8
通讯作者:
Wang J
Wang J
中科院分区:
生物学2区
文献类型:
--
作者:
Chen W;Mook RA Jr;Premont RT;Wang J

文献摘要

参考文献

被引文献

相似文献

氯硝柳胺是一种口服抗寄生虫药物,用于治疗全球数百万人的寄生虫感染。然而,最近的研究表明,氯硝柳胺可能在治疗寄生虫引起的疾病以外的疾病方面具有广泛的临床应用。这些疾病和症状可能包括癌症、细菌和病毒感染、代谢性疾病,如II型糖尿病、NASH和NAFLD、动脉收缩、子宫内膜异位症、神经性疼痛、类风湿性关节炎、硬皮病性移植物抗宿主病和系统性硬化症。与氯硝柳胺药物作用相关的潜在机制包括氧化磷酸化的解偶联,以及对Wnt/β-连环蛋白、mTORC1STAT3、NF-κB和Notch信号通路的调节。在这里,我们简要概述氯硝柳胺的生物活性,其潜在的临床应用,以及它作为一种新的系统性疾病治疗方法所面临的挑战。氯硝柳胺是一种口服抗寄生虫药物,用于治疗寄生虫感染。氯硝柳胺是一种多功能药物,可抑制多种信号通路和生物过程。氯硝柳胺具有潜在的抗全身疾病的生物活性。
Niclosamide is an oral antihelminthic drug used to treat parasitic infections in millions of people worldwide. However recent studies have indicated that niclosamide may have broad clinical applications for the treatment of diseases other than those caused by parasites. These diseases and symptoms may include cancer, bacterial and viral infection, metabolic diseases such as Type II diabetes, NASH and NAFLD, artery constriction, endometriosis, neuropathic pain, rheumatoid arthritis, sclerodermatous graft-versus-host disease, and systemic sclerosis. Among the underlying mechanisms associated with the drug actions of niclosamide are uncoupling of oxidative phosphorylation, and modulation of Wnt/β-catenin, mTORC1, STAT3, NF-κB and Notch signaling pathways. Here we provide a brief overview of the biological activities of niclosamide, its potential clinical applications, and its challenges for use as a new therapy for systemic diseases. Niclosamide is an oral antihelminthic drug used to treat parasitic infections. Niclosamide is a multifunctional drug inhibiting multiple signaling pathways and biological processes. Niclosamide has biological activities potentially against systemic diseases.
DOI: 10.3390/toxins8030069
发表时间: 2016-03-10
期刊: Toxins
影响因子: 4.2
作者:
Friebe S;van der Goot FG;Bürgi J
通讯作者: Bürgi J
前列腺癌中的神经内分泌分化:辐射抗性和治疗衰竭的机制。
DOI: 10.3389/fonc.2015.00090
发表时间: 2015
影响因子: 4.7
作者:
Hu CD;Choo R;Huang J
通讯作者: Huang J
氯硝柳胺是 I 类代谢型谷氨酸受体的负变构调节剂:对神经性疼痛的影响
DOI: 10.1007/s11095-016-2027-9
发表时间: 2016-12-01
影响因子: 3.7
作者:
Ai, Ni;Wood, Richard D.;Welsh, William J.
通讯作者: Welsh, William J.
DOI: 10.1111/j.1469-0691.2006.01589.x
发表时间: 2007-03-01
影响因子: 14.2
作者:
Benfield, T.;Espersen, F.;Skinhoj, P.
通讯作者: Skinhoj, P.
DOI: 10.1387/ijdb.093049ab
发表时间: 2010-01-01
影响因子: 0.7
作者:
Bigas, Anna;Robert-Moreno, Alex;Espinosa, Lluis
通讯作者: Espinosa, Lluis